TRCT
CVRX icon

Tower Research Capital (TRC)’s CVRx CVRX Stock Holding History

Tower Research Capital (TRC)’s Portfolio CVRX Stock Details CVRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.4K Sell
1,206
-1,069
-47% -$7.82K ﹤0.01% 3847
2025
Q4 		$16.2K Buy
2,275
+546
+32% +$4.98K ﹤0.01% 3264
2025
Q3 		$14K Sell
1,729
-1,527
-47% -$11.5K ﹤0.01% 3638
2025
Q2 		$19.1K Buy
3,256
+2,096
+181% +$14.5K ﹤0.01% 3707
2025
Q1 		$14.2K Sell
1,160
-2,740
-70% -$38.7K ﹤0.01% 3310
2024
Q4 		$49.4K Buy
3,900
+1,186
+44% +$14.6K ﹤0.01% 2557
2024
Q3 		$23.9K Buy
2,714
+368
+16% +$3.35K ﹤0.01% 3140
2024
Q2 		$28.1K Buy
2,346
+856
+57% +$9.86K ﹤0.01% 3535
2024
Q1 		$27.1K Buy
1,490
+428
+40% +$10.1K ﹤0.01% 2733
2023
Q4 		$33.4K Sell
1,062
-2,030
-66% -$38.1K ﹤0.01% 3360
2023
Q3 		$46.9K Buy
3,092
+2,357
+321% +$38.8K ﹤0.01% 2598
2023
Q2 		$11.3K Sell
735
-2,241
-75% -$27.3K ﹤0.01% 3986
2023
Q1 		$28K Buy
+2,976
New +$39.4K ﹤0.01% 3063
2022
Q4 		– Sell
-9,382
Closed -$88K – 5953
2022
Q3 		$88K Buy
+9,382
New +$74.3K ﹤0.01% 2672
2022
Q2 		– Sell
-16,640
Closed -$100K – 6134
2022
Q1 		$100K Buy
16,640
+10,363
+165% +$83.7K ﹤0.01% 2193
2021
Q4 		$76K Buy
6,277
+5,631
+872% +$81.7K ﹤0.01% 2426
2021
Q3 		$11K Buy
+646
New +$12.4K ﹤0.01% 4214

Other funds holding CVRX

JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GP
GSK plc London $599M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tower Research Capital (TRC)'s CVRX Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its CVRx (CVRX) stake by 47% in Q1 2026, selling an estimated $7.82K and leaving 1,206 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3847.

Tower Research Capital (TRC) first reported a position in CVRX in Q3 2021 and has held it in 17 quarters since. The position peaked at $100K in Q1 2022. 99 funds tracked by Wall St. Rank hold CVRX as of Q1 2026.

  • Tower Research Capital (TRC) held 1,206 shares of CVRx worth $11.4K as of Q1 2026.
  • Tower Research Capital (TRC) sold 1,069 CVRx shares in Q1 2026, an estimated $7.82K.
  • CVRx made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3847 holding.
  • Tower Research Capital (TRC) first reported a position in CVRx in Q3 2021 and has held it in 17 quarters since.
  • Tower Research Capital (TRC)'s CVRx position peaked at $100K in Q1 2022.
  • 99 funds tracked by Wall St. Rank held CVRx as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.